The Cell & Gene Therapy Manufacturing Pathway: Part 3

CELL AND GENE THERAPY INSIGHTS

The Cell & Gene Therapy Manufacturing Pathway: Part 3

June 2016
The Cell & Gene Therapy Manufacturing Pathway: Part 3
Download PDF

Foreword

Time to move away from the ‘your process is your product’ paradigm?

Time to move away from the ‘your process is your product’ paradigm?

Chris Mason, Elisa Manzotti
10 November 2016
Read

Expert Insight

Manufacturing process development of ATMPs within a regulatory framework for EU clinical trial & marketing authorisation applications

Manufacturing process development of ATMPs within a regulatory framework for EU clinical trial & marketing authorisation applications

10 November 2016
Read

Innovator Insight

The key to commercial success: process development & logistical considerations for autologous immunotherapies

The key to commercial success: process development & logistical considerations for autologous immunotherapies

Dan H O’Donnell
10 November 2016
Read

Future Leader Perspective

Uncovering the potential of ultra scale-down tools to enable cost-effective “Quality by Design”

Uncovering the potential of ultra scale-down tools to enable cost-effective “Quality by Design”

Fernanda Masri
10 November 2016
Read